For this and future tissue-based studies using quantitative immunofluorescence, we defined QCCs as those cancer cells concurrently expressing the 75th percentile of HES1 fluorescence intensity and the 25th percentile of pan-AKT and H3K9me2 fluorescence intensity, respectively, in that sample. The gene discussed is AKT1; the disease is cancer.